Duc‐Vinh Pham
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Natural product bioactivities and synthesis 4
- Inflammasome and immune disorders 4
-
- Adipokines, Inflammation, and Metabolic Diseases 4
- Co-authors
- Pil‐Hoon Park (10 shared papers)Nirmala Tilija Pun (1 shared paper)Thuy-Duong Nguyen (8 shared papers)Dong‐Young Choi (3 shared papers)Jee‐Heon Jeong (4 shared papers)Jae‐Hoon Chang (4 shared papers)Hoang-Anh Nguyen (4 shared papers)Mahesh Pandit (2 shared papers)
- Journals
- Archives of Pharmacal Research (2 papers)Molecular Therapy (1 paper)Molecular Oncology (1 paper)Acta Pharmaceutica Sinica B (1 paper)RSC Advances (1 paper)
- Partner nations
- South KoreaVietnam
In The Last Decade
Duc‐Vinh Pham
20 papers receiving 422 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 101
- Drug Discovery 1
- Pharmaceutical Science 23
- Epidemiology 119
- Molecular Biology 186
Countries citing papers authored by Duc‐Vinh Pham
This map shows the geographic impact of Duc‐Vinh Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duc‐Vinh Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duc‐Vinh Pham more than expected).
Fields of papers citing papers by Duc‐Vinh Pham
This network shows the impact of papers produced by Duc‐Vinh Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duc‐Vinh Pham. The network helps show where Duc‐Vinh Pham may publish in the future.
Co-authors
The 25 scholars most cited alongside Duc‐Vinh Pham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 68 | |
| 2 | 2020 | 43 | |
| 3 | 2020 | 42 | |
| 4 | 2021 | 41 | |
| 5 | 2017 | 38 | |
| 6 | 2020 | 38 | |
| 7 | 2018 | 35 | |
| 8 | 2023 | 27 | |
| 9 | 2021 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 9 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2025 | 1 |
About Duc‐Vinh Pham
Duc‐Vinh Pham is a scholar working on Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, Pharmacology and Genetics, having authored 21 papers that have together received 425 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (4 papers), Inflammasome and immune disorders (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Mesenchymal stem cell research (3 papers), Cancer, Lipids, and Metabolism (3 papers), Phytochemistry and Biological Activities (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Cancer Research (101 citations), Drug Discovery (1 citation), Pharmaceutical Science (23 citations), Epidemiology (119 citations) and Molecular Biology (186 citations). Duc‐Vinh Pham has collaborated with scholars based in South Korea and Vietnam. Frequent co-authors include Pil‐Hoon Park, Nirmala Tilija Pun, Thuy-Duong Nguyen, Dong‐Young Choi, Jee‐Heon Jeong, Jae‐Hoon Chang, Hoang-Anh Nguyen, Mahesh Pandit, Thanh Nguyen Le and Nguyen‐Hai Nam. Their work appears in journals such as Archives of Pharmacal Research, Molecular Therapy, Molecular Oncology, Acta Pharmaceutica Sinica B and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.